Care Hospital, Hyderabad   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Hyderabad India (1997)

Organization Overview

First Clinical Trial
2005
NCT00500409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

CARE Hospital | Care Hospital, Road 1, Banjara Hills, Hyderabad - 500034 | CARE Hospitals, Hyderabad, AP, India

Active Ingredients

Drugs in Phase 3 Trials (4)

calcium (1 trial)

parathyroid hormone (Natpara) (1 trial)

safinamide (xadago) (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (1)

stem cells (1 trial)

Drugs in Phase 1 Trials (2)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

Drugs in Other Trials (1)

amiodarone (cordarone) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Infarction (Phase 2)

Myocardial Infarction (Phase 2)

Osteoporosis (Phase 3)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 8